RxDoctor Payments Data

Bradford Dye, MD

Otolaryngology · Oxford, MSNPI 1649245549

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 28.4% of the total. 2025 is the largest year on record at $444, 3.1 times the $143 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in MS, where the typical reported total is $1,327.

$1,406in general payments, 2019–2025

Across 30 payments — averaging $46.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$400
  • Acclarent, Inc$352
  • Sanofi$304
  • Regeneron Healthcare Solutions, Inc.$115
  • GSK$58
  • Olympus America Inc.$52
  • plus $125 from 7 others

What the payments were for

  • Food & beverage$1,406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,406 in reported general payments places this provider in the 50th percentile of 97 otolaryngology providers in Mississippi.

See all otolaryngology providers in Mississippi

Medicare billing

Part B allowed, 2024
$221,646
Medicare patients
983
Services billed
2,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine1,009$7,523
Tobramycin-DexamethasoneTobramycin/Dexamethasone175$6,509
Clotrimazole199$6,076
Fluticasone Propionate433$5,009
Montelukast Sodium558$3,080
Azelastine Hcl106$2,684
Propylthiouracil18$1,366
Mupirocin69$801
Levothyroxine Sodium159$700
ValacyclovirValacyclovir Hcl29$653
Clarithromycin34$587
Fluocinolone Acetonide Oil12$576
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip35$494
Gabapentin103$475
Cyclobenzaprine Hcl124$367

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Oxford

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →